These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 38606460)

  • 1. Recent advances in targeted drug delivery for the treatment of glioblastoma.
    Mao M; Wu Y; He Q
    Nanoscale; 2024 May; 16(18):8689-8707. PubMed ID: 38606460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Vascular Drug Delivery in Cerebral Cancer.
    Humle N; Johnsen KB; Arendt GA; Nielsen RP; Moos T; Thomsen LB
    Curr Pharm Des; 2016; 22(35):5487-5504. PubMed ID: 27464719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
    Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
    Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Development of Glioblastoma Therapeutic Agents.
    Wang Z; Peet NP; Zhang P; Jiang Y; Rong L
    Mol Cancer Ther; 2021 Sep; 20(9):1521-1532. PubMed ID: 34172531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
    Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
    Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in drug delivery technology for the treatment of glioblastoma multiforme.
    Cha GD; Kang T; Baik S; Kim D; Choi SH; Hyeon T; Kim DH
    J Control Release; 2020 Dec; 328():350-367. PubMed ID: 32896613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of Drug Resistance in Glioblastoma.
    Dymova MA; Kuligina EV; Richter VA
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment.
    Mu Y; Zhang Z; Zhou H; Ma L; Wang DA
    Biomater Sci; 2024 Aug; 12(16):4045-4064. PubMed ID: 38993162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.
    Branco F; Cunha J; Mendes M; Vitorino C; Sousa JJ
    ACS Nano; 2024 Jul; 18(26):16359-16394. PubMed ID: 38861272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
    Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
    Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
    Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-Responsive Polymeric Nanocarriers Accelerate On-Demand Drug Release to Combat Glioblastoma.
    Ismail M; Wang Y; Li Y; Liu J; Zheng M; Zou Y
    Biomacromolecules; 2024 Oct; 25(10):6250-6282. PubMed ID: 39259212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
    Jena L; McErlean E; McCarthy H
    Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel delivery strategies for glioblastoma.
    Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
    Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.